Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. While education about opioids is important, it’s clear that what Texans really need is a safer alternative to opioids for pain relief. A Better Alternative for Chronic Pain.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Veriheal

MAY 26, 2022

But one area of cannabis medicine is still lagging behind—research. In turn, cannabis advocates have struggled to properly educate the public with the limited amount of scientific evidence available. states pass relevant legislation and educating doctors about the power of cannabis medicine.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Veriheal

AUGUST 31, 2020

At Veriheal, education and diversity are at the center of our core values. Choosing only 10 winners for the $10,000 in scholarships among the strong applications we received from multiple disciplines and concentrations in higher education—from students of all backgrounds and interests—was extremely difficult. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

SpeedWeed

SEPTEMBER 1, 2021

5, 2020, according to the department’s second annual report of the Missouri Medical Marijuana Regulatory Program. The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate. 6, 2019, and Dec. dispensaries per 100,000) and New Mexico (5.2

Programs 52

Programs Patients Dispensary Cultivation 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. The use of cannabis as a therapeutic and medicinal aid is widely supported.

Consumption 109

Consumption Patients Research and Development Data 109

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

SEPTEMBER 29, 2021

With more states legalizing cannabis for medical and recreational use, TCI recognizes the critical role that education plays in reducing patient adverse outcomes and ensuring the safe use of cannabis. This certification course is also offered to practicing physicians who are eligible to receive ACCME tier-1 credit. TCI was founded by Drs.

Cannabinoids 52

Cannabinoids Education Patients Safety 52

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.” ABOUT THE NATIONAL PSYCHEDELICS ASSOCIATION.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

OCTOBER 18, 2021

Latowsky added, “This partnership is the first of many affiliate programs with health and wellness practitioners including pharmacists, doctors, chiropractors, naturopaths and sleep and pain clinics,” added Mr. Latowsky. 36Eight is a clinical intelligence technology company focused on supporting clinicians to execute individualized medicine.

Data 52

Data Research and Development Patients Cannabinoids 52

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Conducting a Psilocybin Administration Session (20 Hours).

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

AUGUST 29, 2021

This initial export to Brazil marks Avicanna ’s first commercial export of psychoactive Cannabis Extracts into the emerging Brazilian medicinal cannabis market and the delivery of the initial purchase order from the previously announced three (3) year master supply agreement. RHO Phyto is the first medical formulary of advanced “Cannabis 2.0”

Extraction 98

Extraction Supply Chain Research and Development CBD 98

The Joint Blog

JUNE 12, 2019

A large majority of hospice professionals support medical marijuana, according to a new study published in The Journal of Palliative Medicine and published online by the U.S. … Our findings highlight important opportunities to support hospice providers and their patients through education and the development of policies.”

Research and Development 55

Research and Development Marijuana Education Patients 55

SpeedWeed

SEPTEMBER 17, 2021

Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. Wesana outlined five key goals: Gain expertise and information to design psychedelic-assisted therapy programs for TBI and improve the Wesana timeline and path to market for its treatments.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

MMJ Recs

MARCH 16, 2024

Market size refers to the total value of medical cannabis sales, encompassing both medicinal and adult-use markets. This includes initiatives such as equity licensing programs, which prioritize licenses for individuals from communities disproportionately impacted by past drug policies.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

JUNE 9, 2022

Andrew Freedman, Executive Director, Coalition for Cannabis Policy, Education, and Regulation. Shanita Penny, Senior Advisor, Coalition for Cannabis Policy, Education, and Regulation. Panelists: David Crawford, Senior Program Manager, Code for America. Katie Mueller, Senior Program Manager, National Safety Council.

Policy 52

Policy Safety Seed-To-Sale Data 52

SpeedWeed

MAY 21, 2021

The overwhelming majority of United States clinicians believe cannabis has medicinal value, according to a new survey released last month. Clinicians who believed cannabis had medicinal uses had 5.9 Overwhelming majorities of patients and their providers acknowledge that cannabis is a legitimate medicine.

Medicine 52

Medicine Patients Policy Conditions 52

SpeedWeed

APRIL 29, 2021

“What ended up happening was that the company had sent over some workers from different locations because this is a purely medicinal facility [in Hanover] and the [adult-use] locations for Curaleaf had closed,” Local 328 Director of Organizing Sam Marvin said. “So, And, so, essentially that made up some of the challenged votes.”.

Programs 52

Programs Seed-To-Sale Dispensary Cultivation 52

Cannabis Law Report

SEPTEMBER 23, 2021

This data will assist Awakn’s progress by enabling a better design and more efficient execution of its clinical program. The College’s 20,000 students and 8,000 staff are working to solve to the biggest challenges in science, medicine, engineering, and business.

Research and Development 52

Research and Development Therapy Treatment Data 52

Cannabis Law Report

NOVEMBER 3, 2021

Zerenia™ Clinics UK will build upon Khiron’s presence in the UK which started in 2019 when Khiron became a founding member and also the exclusive Latin American supplier for Project Twenty21 which offers a subsidized pricing model for patients in the program to help address barriers to access in the UK market.

Therapy 52

Therapy Access Patients Treatment 52

SpeedWeed

AUGUST 31, 2021

5, 2020, according to the department’s second annual report of the Missouri Medical Marijuana Regulatory Program. The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate. 6, 2019, and Dec. dispensaries per 100,000) and New Mexico (5.2

Consumption 57

Consumption Programs Patients Dispensary 57

SpeedWeed

AUGUST 31, 2021

5, 2020, according to the department’s second annual report of the Missouri Medical Marijuana Regulatory Program. The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate. 6, 2019, and Dec. dispensaries per 100,000) and New Mexico (5.2

Agriculture 53

Agriculture Programs Patients Dispensary 53

Cannabis Law Report

AUGUST 11, 2021

We believe that the alignment of both companies to offer the highest standards for cannabinoid-based medicine and education will yield fruitful and long-term commercial success,” stated Aras Azadian, CEO of Avicanna. About Heritage Cannabis Holdings Corp. operating under two licensed manufacturing facilities in Canada.

Topical 98

Topical Research and Development Seed-To-Sale Pharmaceutical 98

The Blunt Truth

MAY 26, 2020

Hemp Production Remains Relatively Unscathed, Supported by Demand and Federal Programs. 3] Hemp growers, like other farmers, are further supported by federal programs. 3] Hemp growers, like other farmers, are further supported by federal programs.

CBD 103

CBD Hemp Programs Food 103

SpeedWeed

MAY 22, 2021

Allowing therapist trainees to enroll in [this study] will support the goals of the MDMA Therapy Training Program to provide comprehensive training to future providers,” said MAPS PBC Director and Head of Training and Supervision Shannon Carlin, MA, LMFT in a statement.

Clinical Trials 52

Clinical Trials Therapy Legalization Research and Development 52

Cannabis Law Report

NOVEMBER 6, 2019

Earlier this year, the FDA petitioned the industry to provide safety and efficacy data to the agency so that it may appropriately regulate products containing the increasingly popular ingredient cannabidiol, also known as CBD. About ValidCare.

Hemp 45

Hemp Data Access Education 45

Peninsula Alternative Health

MARCH 1, 2018

The common mission of these nonprofits and trade associations is to educate on the benefits of medical cannabis and create legislative change for businesses, physicians, and qualifying patients. ASA works with a grassroots base of more than 50,000 members using public education and direct advocacy to affect national change.

Treatment 40

Treatment Education Advocacy Access 40

Peninsula Alternative Health

MARCH 1, 2018

The common mission of these nonprofits and trade associations is to educate on the benefits of medical cannabis and create legislative change for businesses, physicians, and qualifying patients. ASA works with a grassroots base of more than 50,000 members using public education and direct advocacy to affect national change.

Treatment 40

Treatment Education Advocacy Access 40

Cannabis Law Report

JULY 29, 2021

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.

Extraction 98

Extraction Supply Chain THC Research and Development 98

Cannabis Law Report

NOVEMBER 19, 2021

MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. We are committed to continuing to lead the field of psychedelic medicine with integrity and ethics at the core. Why work for MAPS Public Benefit Corporation (MAPS PBC)?

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

The Cannigma

MARCH 14, 2023

In fact, its history as a dangerous, illicit narcotic is dwarfed by its history as a medicine. This included whether they had access to educational information about cannabis. Cannabis has been used as a therapeutic tool across the globe for thousands of years. In the mid 1990s something changed.

Policy 96

Policy Research and Development Conditions Consumption 96

Cannabis Law Report

JULY 30, 2019

For now, both Florida’s restrictions and federal restrictions on the scheduling of cannabis still apply as states scramble to formulate respective regulations for research, access, education, innovation. In my estimation, the state’s overall program growth in Florida to date is impressive.

Marijuana 40

Marijuana Education Patients Research and Development 40

MMJ Recs

FEBRUARY 23, 2024

The foundational framework was laid with the establishment of the Michigan Medical Marijuana Program in 2008, signalling the state’s commitment to providing legal access to cannabis for qualified patients. Dispensaries serve as community hubs, providing education and awareness, destigmatizing cannabis use, and fostering inclusivity.

Marijuana 52

Marijuana Dispensary Research and Development Supply Chain 52

MedicalJane

DECEMBER 6, 2017

The legislation was sponsored by Senator Diane Savino, a proponent of the inclusion since the program’s infancy. Legislators initially included PTSD in the state’s program. A 2017 Annals of Internal Medicine review , however, found insufficient evidence to draw any conclusions. Zucker, who recommended the exclusion.

Programs 47

Programs Legislation Patients Education 47

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. History of compliance with regulations and policies governing government regulated marijuana programs. Criterion 2. Criterion 5.

Law 40

Law Marijuana Education Safety 40

Medicinal Genomics

SEPTEMBER 27, 2018

Medicinal Genomics feels this is a significant liability for the cannabis industry as a whole. Within this blog post, we have identified the statements included in the Analytical Cannabis article that Medicinal Genomics knows to be false, those that are true, as well as supplemental data on our position on each specific issue.

Food 69

Food Data Safety Patients 69

Cannabis Law Report

NOVEMBER 9, 2021

Delic” or the “Company”) (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in new medicines and treatments for a modern world, today announced the official, completed acquisition of Ketamine Wellness Centers Arizona LLC (“KWC”), becoming the largest chain of wellness centers providing ketamine treatments in the U.S.

Treatment 52

Treatment Therapy Media Access 52